![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB |
![[thumbnail of Supplemental Material]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplemental Material)
9MB |
| Item Type: | Article |
|---|---|
| Title: | The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation |
| Creators: |
Wortham, Matthew, Ramms, Bastian, Zeng, Chun, Benthuysen, Jacqueline R., Sai, Somesh  ORCID: https://orcid.org/0000-0001-6865-341X, Pollow, Dennis P., Liu, Fenfen, Schlichting, Michael, Harrington, Austin R., Liu, Bradley, Prakash, Thazha P., Pirie, Elaine C., Zhu, Han, Baghdasarian, Siyouneh, Lee, Sean T., Ruthig, Victor A., Wells, Kristen L., Auwerx, Johan, Shirihai, Orian S. and Sander, Maike ORCID: https://orcid.org/0000-0001-5308-7785
|
| Abstract: | Selective and controlled expansion of endogenous β cells has been pursued as a potential therapy for diabetes. Ideally, such therapies would preserve feedback control of β cell proliferation to avoid excessive β cell expansion. Here, we identified a regulator of β cell proliferation whose inactivation resulted in controlled β cell expansion: the protein deacetylase sirtuin 2 (SIRT2). Sirt2 deletion in β cells of mice increased β cell proliferation during hyperglycemia with little effect under homeostatic conditions, indicating preservation of feedback control of β cell mass. SIRT2 restrains proliferation of human islet β cells, demonstrating conserved SIRT2 function. Analysis of acetylated proteins in islets treated with a SIRT2 inhibitor revealed that SIRT2 deacetylates enzymes involved in oxidative phosphorylation, dampening the adaptive increase in oxygen consumption during hyperglycemia. At the transcriptomic level, Sirt2 inactivation has context-dependent effects on β cells, with Sirt2 controlling how β cells interpret hyperglycemia as a stress. Finally, we provide proof of principle that systemic administration of a glucagon-like peptide 1–coupled (GLP1-coupled), Sirt2-targeting antisense oligonucleotide achieves β cell Sirt2 inactivation and stimulates β cell proliferation during hyperglycemia. Overall, these studies identify a therapeutic strategy for increasing β cell mass in diabetes without circumventing feedback control of β cell proliferation. Future work should test the extent to which these findings translate to human β cells from individuals with or without diabetes. |
| Keywords: | Cell Proliferation, Hyperglycemia, Insulin-Secreting Cells, Knockout Mice, Sirtuin 2, Animals, Mice |
| Source: | Journal of Clinical Investigation |
| ISSN: | 0021-9738 |
| Publisher: | American Society for Clinical Investigation |
| Volume: | 135 |
| Number: | 19 |
| Page Range: | e187020 |
| Date: | 1 October 2025 |
| Official Publication: | https://doi.org/10.1172/JCI187020 |
| PubMed: | View item in PubMed |
| Related to: |
Repository Staff Only: item control page
